Drug intelligence / Profile preview

polyquaternium-1

Development stage
Unknown
Lead developer
Alcon
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic, Topical
01

Overview

Polyquaternium-1 is a synthetic polycationic polymer belonging to the quaternary ammonium compound class, used primarily as a **preservative** in ophthalmic (eye drop) formulations and some contact lens solutions[1][2][4]. It inhibits the growth of microbial contaminants in multi-dose topical solutions, providing broad-spectrum antimicrobial activity with relatively low cytotoxicity compared to older preservatives like benzalkonium chloride[2][4]. In addition to its ophthalmic use, it is employed in personal care products (e.g. hair conditioners, shampoos, and skin lotions) as a film-forming and antistatic agent, where its positive charge allows it to neutralize negatively charged surfaces like hair and skin, thus helping to smooth and condition these substrates[3][4][5]. Polyquaternium-1 does not have pharmacological activity via a biological receptor; its function is based on physical-chemical antimicrobial action due to the presence of permanently charged quaternary ammonium groups in its polymer backbone[1][2][4].

Brand names
PolyquadOnaMer MOnyxsperse 12SOnyxsperse12SOnyxsperse-12S
Other names
polidronium chloridepolyquat 1polyquat1polyquat-1polyquaternary ammonium salt -1polyquaternium Ipolyquaternium-1/PQ-1travoprost impurity 53

Beyond the preview

Go deeper on polyquaternium-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyquaternium-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call